Related Experiment Video
Updated: Aug 9, 2025

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance
Abstract:
Telomere length maintenance is essential for cellular immortalization and tumorigenesis. 5% - 10% of human cancers rely on a recombination-based mechanism termed alternative lengthening of telomeres (ALT) to sustain their replicative immortality, yet there are currently no targeted therapies. Through CRISPR/Cas9-based genetic screens in an ALT-immortalized isogenic cellular model, here we identify histone lysine demethylase KDM2A as a molecular vulnerability selectively for cells contingent on ALT-dependent telomere maintenance. Mechanistically, we demonstrate that KDM2A is required for dissolution of the ALT-specific telomere clusters following homology-directed telomere DNA synthesis. We show that KDM2A promotes de-clustering of ALT multitelomeres through facilitating isopeptidase SENP6-mediated SUMO deconjugation at telomeres. Inactivation of KDM2A or SENP6 impairs post-recombination telomere de-SUMOylation and thus dissolution of ALT telomere clusters, leading to gross chromosome missegregation and mitotic cell death. These findings together establish KDM2A as a selective molecular vulnerability and a promising drug target for ALT-dependent cancers.
Insights
Scientists identified histone lysine demethylase KDM2A as a key vulnerability in cancers using alternative lengthening of telomeres (ALT). Targeting KDM2A offers a promising new therapeutic strategy for these specific tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Telomere length maintenance is crucial for cellular immortalization and cancer development.
- Alternative lengthening of telomeres (ALT) is a recombination-based mechanism enabling replicative immortality in 5-10% of human cancers.
- Currently, no targeted therapies exist for ALT-dependent cancers.
Approach:
- Utilized CRISPR/Cas9 genetic screens in an ALT-immortalized cellular model.
- Identified histone lysine demethylase KDM2A as a selective molecular vulnerability.
- Investigated the mechanistic role of KDM2A in ALT telomere maintenance.
Key Points:
- KDM2A is essential for the dissolution of ALT-specific telomere clusters post-homology-directed telomere DNA synthesis.
- KDM2A facilitates SENP6-mediated SUMO deconjugation at telomeres, promoting de-clustering of ALT multitelomeres.
- Inactivation of KDM2A or SENP6 disrupts telomere de-SUMOylation, leading to chromosome missegregation and cell death.
Conclusions:
- KDM2A is a critical factor in ALT telomere maintenance and cluster dissolution.
- KDM2A represents a selective molecular vulnerability for ALT-dependent cancers.
- KDM2A is a promising drug target for treating ALT-driven malignancies.
More Related Videos
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
08:12Global Level Quantification of Histone Post-Translational Modifications in a 3D Cell Culture Model of Hepatic Tissue
Published on: May 5, 2022
Related Concept Videos
Histone Variants at the Centromere
Replicative Cell Senescence
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Spreading of Chromatin Modifications
Writers
The writer...
Telomeres and Telomerase